Correlation between endothelial function and hypertension

Slides:



Advertisements
Similar presentations
Allen Jeremias MD MSc, Sanjay Kaul MD, Luis Gruberg MD, Todd K. Rosengart MD, David L. Brown MD Divisions of Cardiovascular Medicine and Cardiothoracic.
Advertisements

The INSIGHT study - Reliable blood pressure control and additional benefits for hypertensive patients Anthony M Heagerty Department of Medicine Manchester.
Role of Antiretroviral Therapy, Viral Replication, and HIV Infection in Atherosclerosis Priscilla Y. Hsue, Peter W. Hunt, Jeffrey N. Martin, Amanda Schnell,
Surrogate Measures of Atherosclerosis and Implications for Evaluating Cardiovascular Risk Nathan D. Wong, Ph.D., F.A.C.C. Associate Professor and Director.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Cardiovascular Epidemiology: Definitions Historical Perspectives and Assessing Risk of CVD Recent trends and population differences in CHD and CHD risk.
© Arginine Benefits LLC, 2013Author: Dr. Rainer BögerPage 1 Arginine Cardio: Evidence-based reduction of blood pressure (1) L-Arginine is the precursor.
BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.
Prognostic Utility of Secretory Phospholipase A 2 in Patients with Stable Coronary Artery Disease M. O'Donoghue, Z. Mallat, D.A. Morrow, J. Benessiano,
PAD AND VASCULAR EVENTS  IC AS A DISEASE OFTEN REMAINS UN RECOGNISED. AS HIGH AS 75% OF PEOPLE WHO HAVE IC DO NOT SEEK MEDICAL HELP SINCE MANY PEOPLE.
Atherosclerosis Part 1 Atherosclerosis The general term for hardening of the arteries The most prevalent form of atherosclerosis is characterized by the.
10 Points to Remember on the Assessment of Cardiovascular RiskAssessment of Cardiovascular Risk Summary Prepared by Melvyn Rubenfire, MD.
Endothelial Dysfunction as a Marker of Cardiovascular Events Robert A. Vogel, M.D.
Atherosclerotic Disease of the Carotid Artery Atherosclerosis is a degenerative disease of the arteries resulting in plaques consisting of necrotic cells,
1 Multivariable Modeling. 2 nAdjustment by statistical model for the relationships of predictors to the outcome. nRepresents the frequency or magnitude.
VBWG Growth in heart disease, 2000–2050 Deaths Population Foot DK et al. J Am Coll Cardiol. 2000;35:
DIABETES INSTITUTE JOURNAL CLUB CARINA SIGNORI, D.O., M.P.H. DECEMBER 15, 2011 Atherothrombosis intervention in metabolic syndrome with low HDL/High Triglycerides:
Kelsey Vonderheide, PA1.  Heart Failure—a large number of conditions affecting the structure and function of the heart that make it difficult for the.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Left Ventricular Filling Pressure by Doppler Echocardiography in Patients With End-Stage Renal Disease Angela Y-M Wang, Mei Wang, Christopher W-K Lam,
Khripun Irina 1, Vorobyev Sergey 1, Kogan Michael 1, Zitzmann Michael 2 1: Rostov State Medical University, Russia; 2: University Clinics, Centre for Reproductive.
Inflammatory Bowel Disease Is Associated With an Increased Incidence of Cardiovascular Events Andres J. Yarur, MD, Amar R. Deshpande, MD, David M. Pechman,
A Clinical and Echocardiographic Score for Assigning Risk of Major Events After Dobutamine Echocardiograms JACC Vol. 43, No June 2, 2004:2102–7.
Summary of “A randomized trial of standard versus intensive blood-pressure control” The SPRINT Research Group, NEJM, DOI: /NEJMoa Downloaded.
Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE
Dr. Quan, Dr. Mirhashemi, Dr. Chiang
Total Occlusion Study of Canada (TOSCA-2) Trial
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
1 Figure 1: Patient Setup and Sample VENDYS DTM Report
The role of unknown risk factors in coronary heart disease
From ESH 2016 | POS 3C: Chiara Lorenzi, MD
Obesity Hypertension and Endothelial Dysfunction in Pediatric Patients
Health and Human Services National Heart, Lung, and Blood Institute
The Role of Cardiac CT in Women
Copyright © 2007 American Medical Association. All rights reserved.
The Anglo Scandinavian Cardiac Outcomes Trial
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations Cardiology 2015;132: DOI: / Fig. 1. Semilogarithmic.
The following slides highlight a presentation at the Hotline Session of the European Society of Cardiology Annual Congress, September 3-7, 2005 in Stockholm,
Tissue ACE trials in patients with CAD and preserved LV function
RAAS Blockade: Focus on ACEI
Traditional parenteral antihypertensive treatment
Lower Fingertip Temperature Rebound is Associated with Higher Burden of Cardiovascular Risk Factors Measured by Framingham Risk Score.
Systolic Blood Pressure Intervention Trial (SPRINT)
The percentage of subjects with de novo development of renal function impairment (GFR
Progress and Promise in RAAS Blockade
The following slides highlight a presentation at the Late-Breaking Clinical Trials session of the American Heart Association Scientific Sessions, November.
Diastolic heart failure
The following slides highlight a report on a presentation at the Canadian Cardiovascular Congress held in Toronto, Ontario from October 24 to 29, 2003.
The following slides highlight a report on a presentation at the Late-breaking Trials Session and a Satellite Symposium of the American Heart Association.
These slides highlight a cardiology grand rounds and cardiology research rounds presented by William James Howard, MD at St. Michael’s Hospital, in Toronto,
The progression from CV risk factors to endothelial injury and clinical events Content Points: Well-recognized cardiovascular risk factors (hypertension,
Focus: Lipids and the endothelium
The Hypertension in the Very Elderly Trial (HYVET)
A: Epidemiology update
Section 7: Aggressive vs moderate approach to lipid lowering
Relative risks for heart failure: Framingham Study
Insights from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Cardiovascular disease: Leading cause of death
Paradoxical Preservation of Vascular Function in Severe Obesity
Giuseppe Biondi Zoccai, MD
Christopher D. Owens, MD, MSc  Journal of Vascular Surgery 
Christopher D. Owens, MD, MSc  Journal of Vascular Surgery 
Figure 1 Diagram showing analysis flow of patient selection and treatment allocation of ONTARGET/TRANSCEND. Figure 1 Diagram showing analysis flow of patient.
LRC-CPPT and MRFIT Content Points:
Section IV: The interaction of the RAS and lipids
The following slides are from a Cardiology Scientific Update in which Dr. Gordon Moe reported and discussed an original presentation by Drs. Bjorn Dahlof,
These slides highlight a report from a Hotline Session and a Satellite symposium held at the European Society of Cardiology Congress, 2003 in Vienna Austria,
The following slides highlight a report by Dr
Baseline Characteristics of the Subjects*
These slides highlight a Satellite Symposium at the European Society of Cardiology (ESC) Congress 2007 in Vienna, Austria, September 1-5, Originally.
Presentation transcript:

Correlation between endothelial function and hypertension Content Points: The endothelium plays a pivotal role in maintaining hemostasis and tone in blood vessels. The impact of hypertension on endothelial function is seen in these two studies. Panza and colleagues, as seen on the left, showed that hypertensive patients have reduced endothelium-mediated forearm blood flow during cholinergic vasodilation, which was induced by infusion of acetylcholine, as compared with subjects with normal blood pressure.36 Taddei and colleagues showed that endothelium-mediated vasodilation in the forearm is reduced in subjects with a family history of hypertension compared with those who do not have a family history of hypertension.37 Both studies show that hypertension is associated with changes in the endothelium that lead to endothelial dysfunction.

Correlation between endothelial function and atherosclerosis Content Points: Hashimoto and colleagues examined whether endothelial dysfunction in the brachial artery is related to the intima-media thickness of the carotid artery in 34 men with atherosclerosis (mean age 61 years) and 33 age-matched men without atherosclerosis.38 The change in FMD in the brachial artery in reactive hyperemia is widely accepted as a means to evaluate endothelial function. Intima-media thickness of the common carotid artery is used as a surrogate end-point to assess the progression and regression of atherosclerosis. As shown in the slide, the group with atherosclerosis had significantly greater intima-media thickness of the common carotid artery than the control group (P < .05). During reactive hyperemia, the increase in FMD the group with atherosclerosis was significantly smaller than in the control group (P < .01). There was a significant negative correlation between the intima-media thickness of the carotid artery and percent increased FMD. These findings support the concept that endothelial dysfunction is significantly related to atherogenesis. The next few slides will show recent findings regarding the correlation between endothelial function and cardiovascular risk.

Severe endothelial dysfunction associated with increased CV risk in patients with mild CAD Content Points: In this study 157 patients with mildly diseased coronary arteries were studied to determine the association of endothelial dysfunction and future cardiac events.39 Patients were divided into three groups on the basis of their response to acetylcholine. Group 1 (N = 83) included patients with normal coronary endothelial function, which was defined as an increase of > 50% in coronary blood flow in response to acetylcholine. Group 2 (N = 32) included patients with mild endothelial dysfunction, which was defined as a 0% to 50% change in coronary blood flow in response to acetylcholine. Group 3 (N = 42) included patients with severe endothelial dysfunction, which was defined as a decrease in (< 0% change) in coronary blood flow in response to acetylcholine. Over an average 28-month follow-up, none of the patients from groups 1 or 2 had cardiac events. However, 6 (14%) with severe endothelial dysfunction had 10 cardiac events (P < .05 vs groups 1 and 2). Cardiac events included MI, percutaneous or surgical coronary revascularization, and/or cardiac death. Endothelial dysfunction was also evaluated according the epicardial coronary artery diameter response to acetylcholine [% CAD (Ach)]. This division produced results identical to the original classification. This study extends previous observations that early coronary atherosclerosis is associated with endothelial dysfunction. It demonstrates that severe endothelial dysfunction in patients with nonobstructive CAD is associated with increased cardiac events.

Endothelial dysfunction predicts cardiovascular events: 5-year follow-up in patients with angina Content Points: A 5-year follow up of 73 patients with angina pectoris showed endothelial dysfunction, detected by brachial artery ultrasound response to reactive hyperemia, provides prognostic information regarding future cardiac events.40 Cardiac events included MI, or the need for coronary revascularization. Patients with preserved FMD (> 10% change in response to reactive hyperemia, N = 27) and patients with impaired FMD (< 10% change in response to reactive hyperemia, N = 46) differed in their rates of coronary angioplasty (7% vs 37% P = .0003) and bypass surgery (0 vs 15%, P = .009). The groups had similar rates of MI (11% vs 20%, NS), probably due to the low incidence (N = 12) within the 5-year follow-up. FMD evaluation had an 86% sensitivity and a 51% specificity for identifying all cardiac events and a 93% predictive value. After factoring in other risk factors, impaired endothelial function remained independently predictive of cardiac events (P = .0009).

Endothelial function vs clinical outcome in patients with CAD Content Points: In this study, 150 patients with normal or minimally diseased coronary arteries (< 30% diameter stenosis) were studied to determine the relation of endothelial dysfunction to clinical outcomes.41 FMD in the coronary artery was measured following infusion of acetylcholine. Patients were categorized into three groups including low, middle, and upper range of endothelial dysfunction based on the increase in coronary flow with acetylcholine. They were followed for a mean of 24 months. During follow-up, 7 subjects (14%) in the lower third of the study groups developed new symptomatic and angiographically proven CAD, including cardiac death, need for coronary bypass surgery, non-fatal MI, and new or worsening angina (P = .01 for the lower third vs other two groups). Among those with milder endothelial dysfunction, cardiac events occurred in 2% of the patients in the middle group and there were no cardiac events in uppermost group.

Carotid plaque is a marker of CV risk Content Points: This study looked at the associations between carotid-artery intima and media thickness (IMT) and the incidence of new MI or stroke in 4476 subjects aged >65 years without clinical cardiovascular disease.42 The incidence of cardiovascular events correlated with carotid IMT measurements. The relative risk of MI or stroke increased with IMT thickness (P < .001). The estimated cumulative rate of the combined end point for the highest quintile of the combined wall-thickness measure was > 25% at 7 years as compared with < 5% for the lowest quintile. The yearly incidence of the combined end point of MI or stroke increased with increasing quintiles for each of the measures of IMT.

Carotid atherosclerosis and systolic blood pressure Content Points: This study found that hypertensive patients managed in general practice had more advanced atherosclerosis and LVH than matched normotensive patients.43 The case-controlled study included 500 hypertensive cases (systolic BP > 160 mm Hg or diastolic BP > 95 mm Hg) and 506 age- (mean 61 years) and sex- (54% female) matched normotensive controls. Mean systolic BP/diastolic BP levels in 399 treated cases (145/87 mm Hg) were lower than those in untreated cases (158/94 mm Hg) but higher than those in controls (133/82 mm Hg) (P < .0001). Mean carotid artery wall thickness was 10% greater in hypertensive patients than in normotensive controls and LV mass was 14% greater (P < .001), but both were similar in treated and untreated cases of hypertension. Thus hypertensive patients, whether treated with antihypertensive agents or not, had more advanced atherosclerosis and LVH than did matched normotensive patients. Hypertensive patients managed in general practice had persisting atherosclerosis and LVH, despite the fact that the majority were receiving antihypertensive treatment. In multivariate analysis, blood pressure and body mass index were both directly and independently related to carotid wall thickness and LVH (P < .0001). Both obesity and hypertension were cited as potentially modifiable factors to decrease LVH.